Analyst Information


Christopher Raymond

Sr. Research Analyst

Christopher Raymond

Chris Raymond is a managing director and senior research analyst at Piper Jaffray covering the biotechnology sector. Prior to joining Piper, he spent the previous 17 years covering biotechnology at Raymond James, Robert W. Baird and Prudential Vector Healthcare Group. Before that, he spent 10 years with Baxter Healthcare and G. D. Searle in various marketing, business development and strategy roles. Raymond has been recognized twice by StarMine as a top earnings estimator in biotechnology and in 2004 was recognized by The Wall Street Journal "Best on the Street" survey. Raymond received his bachelor's degree from Michigan State University and his Master of Business Administration degree from the University of Chicago Graduate School of Business. He currently serves on the board of the Financial Markets Institute at Michigan State's Broad College of Business.


Allison Bratzel, CFA
Research Analyst
Nicole Gabreski, PhD
Research Analyst
Universe Coverage:
Healthcare:   Biotech
ABBVAbbVie Inc.
AIMTAimmune Therapeutics, Inc.
AKBAAkebia Therapeutics, Inc.
ALXNAlexion Pharmaceuticals, Inc.
AMAGAMAG Pharmaceuticals, Inc.
AMGNAmgen Inc.
ARDXArdelyx, Inc.
BOLDAudentes Therapeutics, Inc.
BIIBBiogen Inc.
BMRNBioMarin Pharmaceutical Inc.
BPMCBlueprint Medicines Corporation
CELGCelgene Corporation
DCPHDeciphera Pharmaceuticals, Inc.
INOInovio Pharmaceuticals, Inc.
REGNRegeneron Pharmaceuticals Inc.
RIGLRigel Pharmaceuticals
RMTIRockwell Medical, Inc
RAREUltragenyx Pharmaceutical, Inc.